Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 8,260 $ 36,589
Restricted cash, current 3,846 3,426
Inventory 5,684 2,954
Prepaids and other current assets 12,794 9,350
Derivative asset 2,205 0
Total current assets 32,789 52,319
Property and equipment, net 368,525 311,400
Restricted cash, non-current 10,600 10,600
Operating lease right-of-use assets 37,099 39,331
Deferred warrant asset 50,175 50,175
Deferred battery supplier cost 30,000 30,000
Other non-current assets 5,158 2,647
Total assets 534,346 496,472
Current liabilities    
Accounts payable 78,045 103,187
Accrued expenses and other current liabilities 63,410 63,091
Convertible debt, current 37,670 34,829
Derivative liability 538 0
Financing liability, current 7,975 0
Warrant liability, current 0 17,171
Total current liabilities 187,638 218,278
Contingent earnout shares liability 170 3,013
Operating lease liabilities 36,523 38,608
Convertible debt, non-current 44,836 0
Financing liability, non-current 23,876 0
Warrant liability, non-current 75,651 0
Total liabilities 368,694 259,899
Commitments and contingencies (Note 11)
Stockholders’ equity    
Preferred stock, $0.0001 par value; 10,000 authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022 0 0
Common stock, $0.0001 par value; 1,000,000 and 500,000 authorized as of September 30, 2023 and December 31, 2022, respectively; 650,946 and 355,388 issued and outstanding at September 30, 2023 and December 31, 2022, respectively 65 35
Additional paid-in capital 1,618,986 1,416,361
Accumulated deficit (1,453,399) (1,179,823)
Total stockholders’ equity 165,652 236,573
Total liabilities and stockholders’ equity $ 534,346 $ 496,472